Wednesday 14 October 2026 Export CI’s income statement to Excel — free account

Cigna Group

Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 6.68%, EPS grew 10.2%, free cash flow grew 66.9% and total debt rose 3.61%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for ten; insiders bought in the last twelve months.

282.53 0.81 −0.29%

Follow CI

Alert me

Market cap: $74.9B
P/E: 11.7×
Fwd P/E: 11.4×
Dividend yield: 2.19%
F-score: 8/9
Altman Z: 2.62
Beneish M: −2.47
Dividend safety: 82/100

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

Total buys 1.00

Total sells 66.84

Totals in millions of $.

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	1	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	2	—	1	1	—	2	1	—

Insider Ownership 1.03%

Capital & Financial Ratios $m

Market Cap 74,870.00

Revenue 282,382.00

Net Income 6,983.00

Free Cash Flow 9,113.00

Net Debt 25,580.00

Current Ratio 0.74

Debt/Equity 0.74

P/E ratio 11.69

Fwd P/E 11.40

P/S ratio 0.26

P/B ratio 1.73

Past 5Y EPS Growth (0.69%)

This Y EPS Growth 2.25%

Next Y EPS Growth 9.72%

Next Y revenue growth 4.57%

Next 5Y EPS Growth 7.57%

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 13.43%

10-year low 10-year high

P/S against its own 10 years 3.54%

10-year low 10-year high

P/B against its own 10 years 33.21%

10-year low 10-year high

EV/Sales against its own 10 years 4.43%

10-year low 10-year high

EV/FCF against its own 10 years 23.03%

10-year low 10-year high

Dividends

Payout Ratio 0.26

Annual Dividend Rate 6.19

Annual Dividend Yield 2.19%

	total	individual payouts
2028	Powerpack
2027	Powerpack
2026	6.18	1.56 1.56 1.56
2025	6.04	1.51 1.51 1.51 1.51
2024	5.60	1.40 1.40 1.40 1.40
2023	4.92	1.23 1.23 1.23 1.23
2022	4.48	1.12 1.12 1.12 1.12
2021	4.00	1.00 1.00 1.00 1.00
2020	0.04	0.04
2019	0.04	0.04
2018	0.04	0.04
2017	0.04	0.04
2016	0.04	0.04

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	7,822	7,550	7,676	6,298
Receivables	22,557	28,605	32,871	34,782
Inventory	—	—	—	—
Other	—	—	—	—
	30,379	36,155	40,547	41,080

	2023	2024	2025	Q'26
Payables	28,368	37,759	40,992	36,634
ST’ Debt	2,775	3,035	592	2,792
Other	5,514	5,388	5,710	6,689
	46,612	55,569	56,342	55,562

Compound Annual Growth %

	10y	5y	3y
Sales	21.92%	11.38%	15.05%
Cash Flow	12.59%	(1.49%)	3.51%
Earnings	11.02%	(6.77%)	(3.86%)
Book Value	13.27%	(3.61%)	(2.14%)

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	68,494	71,668	—	—	—
’25	65,502	67,178	69,748	72,472	274,900
’24	57,255	60,523	63,694	65,649	247,121
’23	46,517	48,586	49,048	51,114	195,265
’22	44,006	45,478	45,281	45,753	180,518
’21	40,971	43,131	44,288	45,679	174,069
’20	38,469	39,265	40,955	41,712	160,401

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	1,131	(421)	—	—	—
’25	1,920	(1,886)	3,418	6,149	9,601
’24	4,840	265	46	5,212	10,363
’23	5,028	2,492	2,826	1,467	11,813
’22	2,030	1,244	3,283	2,099	8,656
’21	1,093	(296)	2,119	4,275	7,191
’20	1,887	3,274	895	4,294	10,350

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	864	(718)	—	—	—
’25	1,593	(2,171)	3,140	5,827	8,389
’24	4,540	(105)	(353)	4,875	8,957
’23	4,620	2,095	2,423	1,102	10,240
’22	1,742	920	2,945	1,754	7,361
’21	851	(554)	1,769	3,971	6,037
’20	1,620	3,018	643	3,975	9,256

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	6.26	6.29	—	—	—
’25	4.85	5.71	6.98	4.64	22.18
’24	(0.97)	5.45	2.63	5.13	12.12
’23	4.24	4.92	4.74	3.49	17.39
’22	3.68	4.90	8.97	3.83	21.30
’21	3.30	4.25	4.80	3.39	15.73
’20	3.15	4.73	3.78	11.45	22.96

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	115.03	133.52	163.02	141.95	118.50	190.88	213.16	240.50	262.03	239.51	Analyst estimates 2026–2028 Powerpack
	High	148.99	212.46	227.13	207.28	224.96	272.81	340.11	327.91	370.83	350.00
People
People	Employees	41,000	46,000	73,800	73,700	73,700	73,700	71,300	72,500	73,500	67,700
	Revenue/emp, $m	0.97	0.91	0.66	2.08	2.18	2.36	2.53	2.69	3.36	4.06
Income, $m
Income, $m	Revenue	39,838	41,806	48,650	153,566	160,401	174,069	180,518	195,265	247,121	274,900
	Gross margin, %	38.90	39.57	43.42	79.93	79.61	80.72	82.17	81.42	84.36	87.50
	EBT	2,979	3,606	3,581	6,570	10,868	6,790	8,397	5,513	5,269	7,781
	EBT margin, %	7.48	8.63	7.36	4.28	6.78	3.90	4.65	2.82	2.13	2.83
	Net income	1,843	2,232	2,646	5,120	8,489	5,420	6,782	5,372	3,778	6,288
	Depreciation	610	566	695	3,651	2,802	2,923	2,937	3,035	2,775	2,775
Per share, $
Per share, $	Revenue	156.01	166.63	197.24	408.51	439.48	515.05	583.17	664.41	881.65	1,030.58
	Earnings	7.19	8.77	10.54	13.44	22.96	15.73	21.30	17.39	12.12	22.18
	Cash flow	15.77	16.29	15.28	25.23	28.36	21.28	27.96	40.20	36.97	35.99
	Capex	(1.81)	(1.88)	(2.14)	(2.79)	(3.00)	(3.41)	(4.18)	(5.35)	(5.02)	(4.54)
	Free cash flow	13.96	14.41	13.14	22.44	25.36	17.86	23.78	34.84	31.96	31.45
	Book value	53.76	54.65	166.37	120.62	137.89	139.45	144.37	157.35	147.14	156.98
	Shares, m	255	251	247	376	365	338	310	294	280	267
Valuation, ×
Valuation, ×	P/E	18.85	23.20	17.75	15.23	9.01	14.59	15.04	17.83	22.56	12.41
	P/S	0.87	1.22	0.96	0.50	0.47	0.45	0.55	0.47	0.31	0.27
	P/B	2.52	3.71	1.14	1.70	1.51	1.65	2.23	1.97	1.88	1.75
	EV/Sales	0.92	1.27	1.76	0.71	0.62	0.61	0.69	0.59	0.41	0.35
	EV/FCF	10.24	14.74	26.36	13.00	10.67	17.59	16.94	11.16	11.37	11.59
Cash, $m
Cash, $m	Operating cash flow	4,026	4,086	3,770	9,485	10,350	7,191	8,656	11,813	10,363	9,601
	Capex	(461)	(471)	(528)	(1,050)	(1,094)	(1,154)	(1,295)	(1,573)	(1,406)	(1,212)
	Free cash flow	3,565	3,615	3,242	8,435	9,256	6,037	7,361	10,240	8,957	8,389
Balance, $m
Balance, $m	Working capital	(20,139)	(19,649)	(12,060)	(12,891)	(8,449)	(12,027)	(12,667)	(16,233)	(19,414)	(15,795)
	Total debt	5,032	5,439	42,478	37,407	32,919	33,670	31,093	30,930	31,972	31,463
	Net debt	1,847	2,467	38,623	32,788	22,737	28,589	25,169	23,108	24,422	23,787
	Shareholders’ equity	13,727	13,711	41,035	45,344	50,328	47,130	44,688	46,244	41,243	41,874
Returns, %
Returns, %	ROA	3.21	3.69	2.45	3.30	5.44	3.46	4.49	3.48	2.23	3.80
	ROIC	12.39	15.23	3.26	6.46	6.97	6.55	7.56	7.69	8.96	8.76
	ROE	14.49	16.31	9.63	11.82	17.68	11.02	14.60	11.36	7.85	14.33

Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
UNH UnitedHealth Group Incorporated	$339.8B	24.3×	23.3×	+0.37% (above 0%: growing)	+61.50% (above 0%: growing)	+62.69% (above 0%: growing)	20.80%	7.13%	Compare
CVS CVS Health Corporation	$112.2B	22.9×	15.4×	+7.26% (above 0%: growing)	+187.65% (above 0%: growing)	+338.29% (above 0%: growing)	44.52%	4.43%	Compare
ELV Elevance Health, Inc.	$91.5B	18.8×	20.3×	+1.40% (above 0%: growing)	−13.08% (below 0%: shrinking)	−9.01% (below 0%: shrinking)	15.77%	4.56%	Compare
CI Cigna Group	$74.9B	11.7×	11.4×	+6.68% (above 0%: growing)	+10.16% (above 0%: growing)	+66.93% (above 0%: growing)	88.24%	3.73%
HUM Humana Inc.	$52.1B	39.5×	42.9×	+26.18% (above 0%: growing)	+27.88% (above 0%: growing)	+58.51% (above 0%: growing)	13.45%	3.33%	Compare
CNC Centene Corporation	$33.1B	— (loss-making)	24.8×	+9.92% (above 0%: growing)	n/m	+116.61% (above 0%: growing)	8.59%	2.24%	Compare
MOH Molina Healthcare, Inc	$10.7B	— (loss-making)	55.0×	−4.84% (below 0%: shrinking)	−74.95% (below 0%: shrinking)	+5.81% (above 0%: growing)	13.19%	1.33%	Compare
OSCR Oscar Health, Inc.	$10.5B	19.8×	29.7×	+70.40% (above 0%: growing)	n/m	+316.29% (above 0%: growing)	22.25%	7.96%	Compare
CLOV Clover Health Investments, Corp.	$2.5B	— (loss-making)	292×	+55.60% (above 0%: growing)	n/m	+406.43% (above 0%: growing)	20.59%	3.77%	Compare
Median of peers	$42.6B	22.9×	27.3×	+8.59%	+27.88%	+89.65%	18.18%	4.10%

All 12 Healthcare Plans stocks →

Cigna Group (CI) key facts

Strength: Cigna Group’s revenue for fiscal 2025 (year ended December 2025) was $274.9 billion, up 11.2% from fiscal 2024.
Strength: Net income was $6.3 billion, or $22.18 per share (basic), a net margin of 2.17%.
Cigna Group (CI) is a Healthcare Plans company in the Healthcare sector, listed on the New York Stock Exchange.
As of October 13, 2026, CI traded at $282.53, a market capitalization of $74.9 billion.
At that price the stock trades at 11.7× trailing-twelve-month earnings and 0.3× sales; its P/E is higher than 13% of its own readings over the past ten years.
Cigna Group pays an annual dividend of $6.19 per share, a yield of 2.19%, with a payout ratio of 25.6%.
Return on equity was 14.3% and debt-to-equity 0.74.
Its Piotroski F-score is 8 out of 9 and its Altman Z-score is 2.62 (grey zone) for fiscal 2025.